Nila Kartika Wati

Scientific Breakthroughs and Social Unrest: A Tense Week at the ADA Annual Conference

• Treatment Innovations

Scientific Breakthroughs and Social Unrest: A Tense Week at the ADA Annual Conference

Nila Kartika Wati July 26, 2026

The American Diabetes Association’s (ADA) annual scientific sessions, typically a sterile environment for the presentation of life-altering...

Read More Read more about Scientific Breakthroughs and Social Unrest: A Tense Week at the ADA Annual Conference

Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy

• Survivorship and Post-Treatment

Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy

Nila Kartika Wati July 25, 2026

PENSACOLA, Florida — For the millions of individuals navigating the labyrinthine reality of a rare disease, the...

Read More Read more about Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy

Beyond the Stigma: Breaking the Silence on Male Breast Cancer

• Survivorship and Post-Treatment

Beyond the Stigma: Breaking the Silence on Male Breast Cancer

Nila Kartika Wati July 25, 2026

While breast cancer is overwhelmingly categorized as a "women’s disease" in the public consciousness, medical data reveals...

Read More Read more about Beyond the Stigma: Breaking the Silence on Male Breast Cancer

The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer

• Patient Advocacy and Support

The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer

Nila Kartika Wati July 25, 2026

Main Facts: A Journey from Diagnosis to Philanthropy At the age of 45, Jessica Conwell was a...

Read More Read more about The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer

From Canvas to Chromosomes: Navigating a Career in Cancer Genomics

• Genomics and Precision Medicine

From Canvas to Chromosomes: Navigating a Career in Cancer Genomics

Nila Kartika Wati July 25, 2026

In the rapidly evolving landscape of modern medicine, the field of cancer genomics stands as a cornerstone...

Read More Read more about From Canvas to Chromosomes: Navigating a Career in Cancer Genomics

Three Decades of Pink: Elizabeth Hurley and the Enduring Legacy of the Breast Cancer Research Foundation

• Patient Advocacy and Support

Three Decades of Pink: Elizabeth Hurley and the Enduring Legacy of the Breast Cancer Research Foundation

Nila Kartika Wati July 24, 2026

Introduction: A Night of Purpose and Philanthropy In the heart of New York City’s social and philanthropic...

Read More Read more about Three Decades of Pink: Elizabeth Hurley and the Enduring Legacy of the Breast Cancer Research Foundation

Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

• Patient Advocacy and Support

Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

Nila Kartika Wati July 24, 2026

In a significant move for the metastatic breast cancer (MBC) community, METAvivor—a leading non-profit organization dedicated to...

Read More Read more about Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

• Breast Cancer Legislation and Policy

The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

Nila Kartika Wati July 23, 2026

In an era defined by rapid technological advancement and profound social fragmentation, the public’s relationship with health...

Read More Read more about The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

• Medical Research and Clinical Trials

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Nila Kartika Wati July 23, 2026

London, UK – In a significant stride towards revolutionizing cancer treatment, scientists at King’s College London have...

Read More Read more about Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition

• Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition

Nila Kartika Wati July 23, 2026

The landscape of metastatic breast cancer treatment has undergone a significant transformation with the U.S. Food and...

Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition